Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2014
07/03/2014WO2014105877A1 Low viscosity meta-stable photoprotection composition
07/03/2014WO2014105874A1 Methods for maintaining bone quality
07/03/2014WO2014105845A1 3-alkyl-5-fluoro-4-substituted-imino-3,4-dihydropyrimidin-2(1h)-one derivatives as fungicides
07/03/2014WO2014105844A1 N-(substituted)-5-fluoro-4-imino-3-methyl-2-oxo-3,4-dihydropyrimidine-1 (2h)-carboxylate derivatives
07/03/2014WO2014105841A1 N-(substituted)-5-fluoro-4-imino-3-methyl-2-oxo-3,4-dihydropyrimidine-1 (2h)-carboxamides derivatives
07/03/2014WO2014105824A2 Instantized product and methods
07/03/2014WO2014105821A1 1-(substituted-benzoyl)-5-fluoro-4-imino-3-methyl-3,4-dihydropyrimidin-2(1h)-one derivatives
07/03/2014WO2014105783A1 Compositions and methods for transdermal delivery of amphetamine and clonidine
07/03/2014WO2014105777A1 Cobicostat dichlohydrate salt
07/03/2014WO2014105666A1 Heterobicyclo-substituted-[1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with a2a antagonist properties
07/03/2014WO2014105664A1 Piperazine-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with a2a antagonist properties
07/03/2014WO2014105655A1 Methods for treating gi tract disorders
07/03/2014WO2014105644A1 Nanoparticle compositions of albumin and paclitaxel
07/03/2014WO2014105635A1 Sterile ophthalmic pharmaceutical suspensions
07/03/2014WO2014105620A1 Use of pregn-4-en-20-yn-3-one for the treatment of depressive disorders
07/03/2014WO2014105576A1 Eicosapentaenoic acid (epa) formulations
07/03/2014WO2014104989A1 Pharmaceutical compositions comprising aripiprazole
07/03/2014WO2014104929A1 Pharmaceutical composition for treatment of hiv infections
07/03/2014WO2014104924A1 Antineoplastic agent (alternatives)
07/03/2014WO2014104904A1 Process for preparation of bosentan monohydrate of pharmaceutical purity
07/03/2014WO2014104757A1 2,3-dihydro-isoindole-1-on derivative as btk kinase suppressant, and pharmaceutical composition including same
07/03/2014WO2014104681A1 Pharmaceutical composition for preventing or treating skin disease comprising eriodictyol compound or a pharmaceutically acceptable salt thereof as an active ingredient
07/03/2014WO2014104671A1 Pharmaceutical composition with improved stability, containing temozolomide, and preparation method therefor
07/03/2014WO2014104650A1 Agent for preventing or inhibiting formation of biofilm including lipoteichoic acid or derivative thereof, and method for preventing or inhibiting formation of biofilm using same
07/03/2014WO2014104607A1 Method for preparing (2-methyl-1-(3-methylbenzyl)-1h-benzo[d]imidazol-5-yl)(piperidin-5-yl)methanone
07/03/2014WO2014104583A1 Process for preparing meropenem trihydrate
07/03/2014WO2014104546A1 Oxacephem formulation having improved stability and method for manufacturing same
07/03/2014WO2014104488A1 Method for preparing carbapenem antibiotics
07/03/2014WO2014104414A1 Salts and crystal forms
07/03/2014WO2014104412A1 Injectable depot formulation comprising optically active tolvaptan and process of producing the same
07/03/2014WO2014104406A1 Therapeutic agent for osteoporosis and method for screening therapeutic agent
07/03/2014WO2014104372A1 Halogen-substituted heterocyclic compound
07/03/2014WO2014104316A1 Sphingomyelin-containing supplement
07/03/2014WO2014104279A1 SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND MEDICINAL USE THEREOF AS HIV INTEGRASE INHIBITOR
07/03/2014WO2014104272A1 Cinnamic acid amide derivative
07/03/2014WO2014104220A1 Packaging
07/03/2014WO2014104209A1 Novel benzazepine derivative and pharmaceutical use thereof
07/03/2014WO2014104171A1 Skin-exterior anti-ageing composition and production method therefor
07/03/2014WO2014104157A1 Method for producing polyphenol composition
07/03/2014WO2014104149A1 Preparation for application to skin
07/03/2014WO2014104148A1 Cephem compound
07/03/2014WO2014104064A1 Wound healing accelerator
07/03/2014WO2014103950A1 (hydroxystilbene compound)-(sinapinic acid) reaction product having antifeeding activity
07/03/2014WO2014103863A1 Screening method for compound having obesity preventive or therapeutic activity
07/03/2014WO2014103862A1 Obesity preventive or therapeutic agent and rheumatism preventive or therapeutic agent
07/03/2014WO2014103801A1 Oct3 activity inhibitor containing imidazopyridine derivative as active component, and oct3 detection agent
07/03/2014WO2014103704A1 Method for producing p1,p4-di(uridine 5'-)tetraphosphate
07/03/2014WO2014103475A1 Skin-exterior anti-ageing composition and production method therefor
07/03/2014WO2014103410A1 Igf-1 production promoter
07/03/2014WO2014103321A1 Pdk4 inhibitor and use thereof
07/03/2014WO2014102889A1 Antitumor agent and method for producing same
07/03/2014WO2014102832A2 Saxagliptin hydrochloride solid dispersion
07/03/2014WO2014102827A1 Process for preparation of ivabradine
07/03/2014WO2014102824A1 Diclofenac composition
07/03/2014WO2014102822A2 Aldehyde derivative of substitute oxazolidinones
07/03/2014WO2014102818A1 Novel quinolone derivatives
07/03/2014WO2014102817A1 Substituted phthalazin-1 (2h)-one derivatives as selective inhibitors of poly (adp-ribose) polymerase-1
07/03/2014WO2014102802A1 Alginate compositions and uses thereof
07/03/2014WO2014102801A1 Use of alginate compositions in preventing or reducing liver damage caused by a hepatotoxic agent
07/03/2014WO2014102788A1 Foamable otic pharmaceutical compositions
07/03/2014WO2014102778A2 Agents for treating genetic diseases resulting from nonsense mutations, and methods for identifying the same
07/03/2014WO2014102755A1 Bortezomib formulations
07/03/2014WO2014102745A1 High drug load ibuprofen sustained release composition
07/03/2014WO2014102731A1 Novel pharmaceutical compositions of romidepsin
07/03/2014WO2014102693A1 Pharmaceutical composition containing a derivative of n-phenylpyrazole and permethrin, and use for the production of a topical veterinary medicament
07/03/2014WO2014102679A1 Novel veterinary pharmaceutical compositions and method for the production thereof
07/03/2014WO2014102678A1 Oil suspension of metronidazole
07/03/2014WO2014102630A1 Solid form of dihydro-pyrido-oxazine derivative
07/03/2014WO2014102628A1 Stable pharmaceutical composition comprising azilsartan medoxomil
07/03/2014WO2014102593A1 Substituted morphinans and the use thereof
07/03/2014WO2014102591A1 PROCESS FOR PREPARING 7β-SUBSTITUTED 6α,14α -ETHENOMORPHINANS AND 7β-SUBSTITUTED 6α,14α-ETHANOMORPHINANS
07/03/2014WO2014102590A1 Substituted piperidin-4-amino-type compounds and uses thereof
07/03/2014WO2014102589A1 Quinazolin-4(3h)-one-type piperidine compounds and uses thereof
07/03/2014WO2014102587A1 7,8-cyclicmorphinan analogs
07/03/2014WO2014102498A1 Dermatological composition comprising a pde7 inhibitor in a dispersed form, method for the production thereof, and use of same
07/03/2014WO2014102497A1 Dermatological composition comprising a pde7 inhibitor in a solubilised form, production method thereof, and use of same
07/03/2014WO2014102434A1 A 1,4,5-trisubstituted1,2,3-triazole mimetic of rgd and/or ogp10-14, process to obtain it and uses thereof
07/03/2014WO2014102429A1 Anticholesteremic fibre combination
07/03/2014WO2014102425A1 Cyclopentanone compounds, method for obtaining them and their use in the preparation of a drug used for treating inflammatory diseases associated with cellular fibrotic and apoptotic processes
07/03/2014WO2014102417A1 USE OF BICYCLIC DERIVATIVES OF 1-DEOXYGALACTONOJIRIMYCIN IN THE PRODUCTION OF A MEDICAMENT FOR THE TREATMENT OF DISEASES ASSOCIATED WITH MUTANT HUMAN LYSOSOMAL GALACTOSIDASE ß-ENZYMES
07/03/2014WO2014102378A1 Azaindole derivatives as inhibitors of protein kinases
07/03/2014WO2014102377A1 Azaindole derivatives as multi kinase inhibitors
07/03/2014WO2014102376A1 Protein kinase inhibitors
07/03/2014WO2014102339A1 Sulphate salts of n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2-amine, preparation thereof and use of the same
07/03/2014WO2014102315A1 Selected macrolides with pde4-inhibiting activity
07/03/2014WO2014102253A1 Monolithic dosage form for the modified release of an active ingredient combination
07/03/2014WO2014102233A1 Comt inhibitors
07/03/2014WO2014102213A1 Aptamers inhibiting the enzymatic activity of tyrosinase
07/03/2014WO2014102090A1 4-hydroxy-2-methyl-5-(propan-2-ylidene)cyclohex-3-enecarbaldehyde for the prevention and treatment of a cognitive, neurodegenerative or neuronal disease
07/03/2014WO2014101986A1 Dry granulation process for producing tablet compositions of metformin and compositions thereof
07/03/2014WO2014101873A1 Alpinia spp. extracts for treating irritable bowel syndrom
07/03/2014WO2014101865A1 Composition of glucose derivative and proline, crystal, preparation method and application
07/03/2014WO2014101765A1 Benzoxazine oxazolidinone compound, preparation method and application thereof
07/03/2014WO2014101373A1 Heterobicyclo-substituted-[1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds for treatment of central nervous system disorder
07/03/2014WO2014101366A1 Methods for inhibition of shc-1/p66 to combat aging-related diseases
07/03/2014WO2014101356A1 Gamabufotalin liposome, preparation method therefor and applicationthereof
07/03/2014WO2014101322A1 Amino acid improving sensitivity of bacteria to serum
07/03/2014WO2014101295A2 Isoxazole derivative that inhibits activity of janus kinases (jaks)
07/03/2014WO2014101134A1 Folic acid derivative, and preparing method and application thereof
07/03/2014WO2014101120A1 Heterobicyclo-substituted-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with a2a antagonist properties
1 ... 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 ... 7860